Replies to post #129309 on Biotech Values

[DewDiligence]

Would VRTX achieve a higher SVR rate with TID dosing for 12 weeks?

That’s highly unlikely based on the results of the ‘C208’ study completed two years ago (#msg-43114192). VRTX is running another study to get BID dosing on the label (#msg-55917427), but BID dosing is already the de facto standard for Incivek.